Journal Logo

Articles by Christopher G. Goetz

Reducing Dosing Frequency of Carbidopa/Levodopa: Double-Blind Crossover Study Comparing Twice-Daily Bilayer Formulation of Carbidopa/Levodopa (IPX054) Versus 4 Daily Doses of Standard Carbidopa/Levodopa in Stable Parkinson Disease Patients

Hinson, Vanessa K.; Goetz, Christopher G.; Leurgans, Sue; More

Clinical Neuropharmacology. 32(4):189-192, July-August 2009.

Show: